Baxter's Global Portfolio:
Emulsion for Infusion
Numeta is approved in select countries outside the U.S.; it is not approved/cleared in the U.S.
Meet NUMETA: The Triple-Chamber, Ready-To-Use IV Nutrition System for Preterm Newborns and Children
NUMETA is the first ready-to-use parenteral (intravenous) nutrition (PN) product available to treat preterm neonates and pediatric patients who have acute nutritional requirements by providing a formulation of amino acids (protein), glucose (carbohydrates), lipids (fats) and electrolytes in a triple-chamber system pioneered by Baxter.
- NUMETA is offered in multiple formulations specifically developed for pediatric patients in different growth stages including NUMETA G13E 300mL, which is the only ready-to-use PN product available for preterm infants.
- Additional NUMETA formulations include NUMETA G16E 500mL for full term infants through two years of age, and NUMETA G19E 1,000mL for children and adolescents (2-18 years of age).
- NUMETA’s design also allows for activation and administration at bedside.
- NUMETA is available in select European and Latin American countries. For prescribing information, please visit us at www.numeta.com.